Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.570
-0.040 (-1.53%)
Nov 4, 2024, 4:00 PM EST - Market closed
Nautilus Biotechnology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 323 | 374 | 225 | 643 | - | - |
| Market Cap Growth | -9.46% | 66.44% | -65.10% | - | - | - |
| Enterprise Value | 214 | 226 | -4 | 299 | - | - |
| Last Close Price | 2.57 | 2.99 | 1.80 | 5.18 | 10.85 | - |
| PE Ratio | - | -5.87 | -3.87 | -8.70 | -20.21 | - |
| PB Ratio | 1.44 | 1.41 | 0.71 | 1.77 | - | - |
| P/FCF Ratio | -5.86 | -6.90 | -4.66 | -15.49 | - | - |
| P/OCF Ratio | -6.09 | -7.23 | -4.90 | -16.39 | - | - |
| EV/EBITDA Ratio | -2.80 | -3.04 | 0.07 | -6.05 | - | - |
| EV/EBIT Ratio | -2.73 | -2.97 | 0.07 | -5.93 | - | - |
| EV/FCF Ratio | -3.65 | -4.17 | 0.09 | -7.21 | - | - |
| Debt / Equity Ratio | 0.14 | 0.13 | 0.10 | 0.08 | 0.06 | - |
| Debt / FCF Ratio | -0.52 | -0.64 | -0.63 | -0.72 | -0.32 | - |
| Quick Ratio | 16.23 | 19.01 | 27.16 | 59.49 | 25.43 | 34.00 |
| Current Ratio | 16.65 | 19.39 | 27.57 | 60.09 | 25.73 | 34.62 |
| Return on Equity (ROE) | -28.04% | -21.95% | -17.07% | -22.75% | -32.29% | - |
| Return on Assets (ROA) | -17.62% | -14.52% | -10.62% | -13.06% | -19.00% | - |
| Return on Capital (ROIC) | -17.94% | -14.75% | -10.76% | -13.23% | -19.38% | - |
| Earnings Yield | -21.76% | -17.04% | -25.80% | -7.82% | - | - |
| FCF Yield | -18.91% | -14.49% | -21.44% | -6.45% | - | - |
| Buyback Yield / Dilution | -0.28% | -0.26% | -47.51% | -190.36% | -379.48% | - |
| Total Shareholder Return | -0.28% | -0.26% | -47.51% | -190.36% | -379.48% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.